乳腺癌患者围手术期免疫指标变化及其临床意义
该研究检测了103例原发性乳腺癌患者和116例乳腺纤维瘤患者术前及术后第1、3、5天外周血Th1细胞、Th2细胞、Th1/Th2比值和调节性T细胞(Treg)比例。结果显示乳腺癌患者术后Th1细胞比例较术前降低、Treg细胞比例较术前增高(均P<0.05),而乳腺纤维瘤患者术后上述指标与术前比较差异无统计学意义(均P>0.05)。Th1细胞和Treg细胞的围手术期变化与肿瘤分化程度、T分期、N分期、TNM分期、HER-2状态、Ki-67及无瘤生存相关。
要点
- 乳腺癌术后Th1细胞比例降低、Treg细胞比例增高,乳腺纤维瘤患者无此变化。
- Th1细胞变化与分化程度、T分期、N分期、TNM分期、HER-2状态、Ki-67有关。
- Th1细胞增加组无瘤生存优于减少组,Treg细胞减少组优于增加组。
核心结论
- Th1细胞和Treg细胞是评价乳腺癌患者细胞免疫功能的重要指标,其围手术期变化与肿瘤病灶大小、病理参数、临床分期及无瘤生存有关。
研究设计与样本
- 检测103例原发性乳腺癌患者和116例乳腺纤维瘤患者术前及术后第1、3、5天外周血Th1细胞比例、Th2细胞比例、Th1/Th2比值和Treg细胞比例。
- 分析外周血T淋巴细胞亚群变化与乳腺癌患者临床病理特征及无瘤生存期的关系。
主要发现
- 乳腺癌组术后第1、3、5天Th1细胞比例分别为(12.20±0.45)%、(13.89±0.47)%、(14.04±0.49)%,较术前[(15.82±0.51)%]降低(均P<0.05)。
- 乳腺癌组术后第1、3、5天Treg细胞比例分别为(3.82±0.13)%、(3.25±0.11)%、(2.95±0.11)%,较术前[(2.53±0.11)%]增高(均P<0.05)。
- 乳腺纤维瘤患者术后第1、3、5天Th1细胞比例、Th2细胞比例和Treg细胞比例与术前比较差异均无统计学意义(均P>0.05)。
- 乳腺癌患者术后Th1细胞的变化与肿瘤分化程度、T分期、N分期、TNM分期、HER-2状态、Ki-67有关(均P<0.05)。
- Treg细胞的变化与肿瘤T分期、N分期、HER-2状态有关(均P<0.05)。
关键数值与推荐
- Th1细胞增加组患者的无瘤生存明显优于Th1细胞减少组(P=0.045)。
- Treg细胞减少组患者的无瘤生存优于Treg细胞增加组(P=0.012)。
临床怎么用
- 围手术期监测外周血Th1细胞和Treg细胞比例变化,可辅助评估乳腺癌患者细胞免疫功能状态。
- Th1细胞和Treg细胞的围手术期变化与肿瘤病理参数及无瘤生存相关,或有助于风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the changes of perioperative immune index in patients with breast cancer and its clinical significance. Methods: Th1 cells, Th2 cells, Th1/Th2 ratio and regulatory T cells (Treg) were detected in peripheral blood of 103 patients with primary breast cancer and 116 patients with breast fibroma before surgery and on the 1st, 3rd and 5th day following operation. The relationship of changes in T lymphocyte subsets and clinicopathological characteristics, as well as tumor-free survival of breast cancer patients, was analyzed. Results: The levels of Th1 cells in breast cancer group on the 1st, 3rd and 5th day following operation were (12.20±0.45)%, (13.89±0.47)%, (14.04±0.49)%, which were significantly lower than those before operation [(15.82 + 0.51)%, all P<0.05 ]. Treg cells, however, with the number of (3.82±0.13)%, (3.25±0.11)%, (2.95 ±0.11)%, were remarkably higher than those before operation [(2.53 ±0.11)%, all P<0.05]. With respect to breast fibroma patients, there was no significant difference compared with those before operation of Th1 cells, Th2 cells and Treg cells (all P>0.05). The changes of Th1 cells were associated with the degree of differentiation, T stage, N stage, TNM stage, HER-2 status and Ki-67 (all P<0.05). Treg cells were related to T stage, N stage and HER-2 status (all P<0.05). Tumor-free survival in the Th1-cell-increasing group was significantly better than that in the Th1-cell-decreasing group (P=0.045), while cell-decreasing group of Treg showed the improved outcomes (P=0.012). Conclusions: The levels of Th1 cells and Treg cells are important indicators of cellular immune function in patients with breast cancer. Moreover, the perioperative changes of Th1 cells and Treg cells are associated with the size of tumors, pathological parameters, clinical stages and tumor-free survival outcomes. 目的: 探讨乳腺癌患者围手术期免疫指标的变化及其临床意义。 方法: 检测103例原发性乳腺癌患者和116例乳腺纤维瘤患者术前及术后第1、3、5天外周血Th1细胞比例、Th2细胞比例、Th1/Th2比值和调节性T细胞(Treg)比例,分析外周血T淋巴细胞亚群变化与乳腺癌患者临床病理特征、无瘤生存期的关系。 结果: 乳腺癌组术后第1、3、5天的Th1细胞比例分别为(12.20±0.45)%、(13.89±0.47)%、(14.04±0.49)%,较术前[(15.82±0.51)%]降低(均P<0.05);Treg细胞比例分别为(3.82±0.13)%、(3.25±0.11)%、(2.95±0.11)%,较术前[(2.53±0.11)%]增高(均P<0.05)。乳腺纤维瘤患者术后第1、3、5天的Th1细胞比例、Th2细胞比例和Treg细胞比例与术前比较,差异均无统计学意义(均P>0.05)。乳腺癌患者术后Th1细胞的变化与肿瘤分化程度、T分期、N分期、TNM分期、人表皮生长因子受体2(HER-2)状态、Ki-67有关(均P<0.05),Treg细胞的变化与肿瘤T分期、N分期、HER-2状态有关(均P<0.05)。Th1细胞增加组患者的无瘤生存明显优于Th1细胞减少组(P=0.045),Treg细胞减少组患者的无瘤生存优于Treg细胞增加组(P=0.012)。 结论: Th1细胞和Treg细胞是评价乳腺癌患者细胞免疫功能的重要指标,其围手术期变化与肿瘤病灶的大小、病理参数、临床分期及患者的无瘤生存有关。.
引用
- Chen R, Chen GP, Wang JH, et al. [The changes of perioperative immunity index in patients with breast cancer and its clinical significance]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31770853. doi:10.3760/cma.j.issn.0253-3766.2019.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。